» Articles » PMID: 8306027

Proinflammatory Cytokines in Nasal Secretions of Allergic Subjects After Antigen Challenge

Overview
Specialty Critical Care
Date 1994 Feb 1
PMID 8306027
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

To study the role of cytokines in allergic late-phase reactions (LPR), we measured cytokines (interleukins [IL]-1 beta, IL-2, IL-4, IL-5, IL-6, and granulocyte-macrophage colony-stimulating factor [GM-CSF]) in nasal secretions (NS) of eight allergic subjects following antigen or saline provocation. NS were collected hourly for 10 h after challenge by a newly developed matrix method. All subjects recorded hourly symptom scores. Cytokines were measured using specific enzyme-linked immunosorbent assays (ELISA). Compared with prechallenge values, significant levels of IL-1 beta were detected in all subjects during the immediate reaction (peak, 51.0 +/- 22.4 pg/ml) and LPR (peak, 78.5 +/- 22.6 pg/ml) after antigen challenges (p < 0.01) but not saline challenges. In contrast, GM-CSF and IL-6 showed a delayed rise (peak, 26.4 +/- 1.3 pg/ml and 33.8 +/- 10.0 pg/ml, respectively) at hour 4 in the antigen-challenge period (p < 0.01 versus saline). NS from 4 donors also showed detectable IL-5 (7.6 to 155 pg/ml) during the immediate reaction and LPR after allergen challenges (versus saline, p < 0.01). The levels of cytokine correlated (p < 0.05) with corresponding total symptom scores during the immediate reaction (IL-1 beta) and LPR (IL-1 beta, GM-CSF, and IL-6). IL-2 and IL-4 were not detected in any sample. Thus, IL-1 beta, IL-5, IL-6, and GM-CSF are present in the LPR of allergic rhinitis, and their correlation with clinical responses may suggest their role in allergic inflammation.

Citing Articles

Interleukin 1β Mediates the Pathogenesis of Nasal Mucosal Epithelial Barrier Dysfunction in Allergic Rhinitis.

Wang H, Song X, Wang Y, Yang T, Liu W, Mou Y J Inflamm Res. 2024; 17:9071-9085.

PMID: 39588138 PMC: 11586497. DOI: 10.2147/JIR.S488340.


The Impact of Cytokines on Health-Related Quality of Life in Adolescents with Allergic Rhinitis.

Krsmanovic L, Arsovic N, Bokonjic D, Nesic V, Dudvarski Z, Pavlovic D Biomedicines. 2024; 12(2).

PMID: 38398030 PMC: 10886792. DOI: 10.3390/biomedicines12020428.


Probiotics for the Management of Oral Mucositis: An Interpretive Review of Current Evidence.

Fallah M, Amin N, Moghadasian M, Jafarnejad S Adv Pharm Bull. 2023; 13(2):269-274.

PMID: 37342370 PMC: 10278207. DOI: 10.34172/apb.2023.029.


IL-1 and Allergy: Focusing on Its Role in Allergic Rhinitis.

Wang H, Wei S, Song X, Wang Y, Zhang W, Ren C Mediators Inflamm. 2023; 2023:1265449.

PMID: 37091903 PMC: 10115535. DOI: 10.1155/2023/1265449.


How an Immune-Factor-Based Formulation of Micro-Immunotherapy Could Interfere with the Physiological Processes Involved in the Atopic March.

Jacques C, Floris I Int J Mol Sci. 2023; 24(2).

PMID: 36675006 PMC: 9864899. DOI: 10.3390/ijms24021483.